260 related articles for article (PubMed ID: 30187393)
1. Modification of existing patient-reported outcome measures: qualitative development of the MD Anderson Symptom Inventory for malignant pleural mesothelioma (MDASI-MPM).
Williams LA; Whisenant MS; Mendoza TR; Haq S; Keating KN; Cuffel B; Cleeland CS
Qual Life Res; 2018 Dec; 27(12):3229-3241. PubMed ID: 30187393
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the psychometric properties and minimally important difference of the MD Anderson Symptom Inventory for malignant pleural mesothelioma (MDASI-MPM).
Mendoza TR; Williams LA; Keating KN; Siegel J; Elbi C; Nowak AK; Hassan R; Cuffel B; Cleeland CS
J Patient Rep Outcomes; 2019 Jun; 3(1):34. PubMed ID: 31209661
[TBL] [Abstract][Full Text] [Related]
3. What symptoms are important to patients? Developing a symptom burden measure for women with breast cancer.
Whisenant MS; Strunk FA; Tripathy D; Williams LA
Support Care Cancer; 2019 Dec; 27(12):4639-4647. PubMed ID: 30937601
[TBL] [Abstract][Full Text] [Related]
4. Validation and application of a module of the MD Anderson Symptom Inventory for measuring perioperative symptom burden in patients with gynecologic cancer (the MDASI-PeriOp-GYN).
Wang XS; Shi Q; Williams LA; Cleeland CS; Garcia-Gonzalez A; Chen TY; Shahid DR; Ramirez PT; Iniesta MD; Siverand AM; Meyer LA
Gynecol Oncol; 2019 Mar; 152(3):492-500. PubMed ID: 30876494
[TBL] [Abstract][Full Text] [Related]
5. Measuring symptom burden in patients with cancer during a pandemic: the MD Anderson symptom inventory for COVID-19 (MDASI-COVID).
Williams LA; Whisenant MS; Mendoza TR; Peek AE; Malveaux D; Griffin DK; Ponce DA; Granwehr BP; Sheshadri A; Hutcheson KA; Ali SM; Peterson SK; Heymach JV; Cleeland CS; Subbiah IM
J Patient Rep Outcomes; 2023 May; 7(1):48. PubMed ID: 37237077
[TBL] [Abstract][Full Text] [Related]
6. Validation and Application of the MD Anderson Symptom Inventory for Traditional Chinese Medicine (MDASI-TCM).
Li Z; Shi Q; Liu M; Jia L; He B; Yang Y; Liu J; Lin H; Lin HK; Li P; Wang XS
J Natl Cancer Inst Monogr; 2017 Nov; 2017(52):. PubMed ID: 29140491
[TBL] [Abstract][Full Text] [Related]
7. Capturing the patient's experience: using qualitative methods to develop a measure of patient-reported symptom burden: an example from ovarian cancer.
Williams LA; Agarwal S; Bodurka DC; Saleeba AK; Sun CC; Cleeland CS
J Pain Symptom Manage; 2013 Dec; 46(6):837-45. PubMed ID: 23615044
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of a patient-reported outcome measure to assess symptom burden after chimeric antigen receptor T-cell therapy.
Wang XS; Srour SA; Mendoza T; Whisenant M; Subbiah I; Gonzalez E; Kamal M; Shen SE; Cleeland C; Kebriaei P; Rezvani K; Neelapu S; Ahmed S; Shpall E
Br J Haematol; 2023 May; 201(4):738-746. PubMed ID: 36733986
[TBL] [Abstract][Full Text] [Related]
9. What Do Patients With Non-Small-Cell Lung Cancer Experience? Content Domain for the MD Anderson Symptom Inventory for Lung Cancer.
Whisenant MS; Williams LA; Garcia Gonzalez A; Mendoza T; Shi Q; Cleeland C; Zhang J; Heymach J; Simon G
JCO Oncol Pract; 2020 Oct; 16(10):e1151-e1160. PubMed ID: 32539654
[TBL] [Abstract][Full Text] [Related]
10. Measuring the symptom burden of lung cancer: the validity and utility of the lung cancer module of the M. D. Anderson Symptom Inventory.
Mendoza TR; Wang XS; Lu C; Palos GR; Liao Z; Mobley GM; Kapoor S; Cleeland CS
Oncologist; 2011; 16(2):217-27. PubMed ID: 21285393
[TBL] [Abstract][Full Text] [Related]
11. The validity and utility of the M. D. Anderson Symptom Inventory in patients with breast cancer: evidence from the symptom outcomes and practice patterns data from the eastern cooperative oncology group.
Mendoza TR; Zhao F; Cleeland CS; Wagner LI; Patrick-Miller LJ; Fisch MJ
Clin Breast Cancer; 2013 Oct; 13(5):325-34. PubMed ID: 23816985
[TBL] [Abstract][Full Text] [Related]
12. Validation and application of a module of the M. D. Anderson Symptom Inventory for measuring multiple symptoms in patients with gastrointestinal cancer (the MDASI-GI).
Wang XS; Williams LA; Eng C; Mendoza TR; Shah NA; Kirkendoll KJ; Shah PK; Trask PC; Palos GR; Cleeland CS
Cancer; 2010 Apr; 116(8):2053-63. PubMed ID: 20166216
[TBL] [Abstract][Full Text] [Related]
13. Patient-Reported Symptom and Functioning Status during the First 12 Months after Chimeric Antigen Receptor T Cell Therapy for Hematologic Malignancies.
Wang XS; Srour SA; Whisenant M; Subbiah IM; Chen TH; Ponce D; Gonzalez AG; Kamal M; Mendoza T; Cleland CS; Kebriaei P; Neelapu SS; Rezvani K; Ahmed S; Shpall E
Transplant Cell Ther; 2021 Nov; 27(11):930.e1-930.e10. PubMed ID: 34265479
[TBL] [Abstract][Full Text] [Related]
14. Development of a patient-reported outcome tool for assessing symptom burden during perioperative care in liver surgery: The MDASI-PeriOp-Hep.
Wang XS; Shi Q; Williams LA; Lillemoe HA; Chen TY; Gottumukkala V; Garcia-Gonzalez A; Malveaux D; Kamal M; Cleeland CS; Aloia TA
Eur J Oncol Nurs; 2021 Jun; 52():101959. PubMed ID: 33964632
[TBL] [Abstract][Full Text] [Related]
15. Advanced Symptom Management System for Patients with Malignant Pleural Mesothelioma (ASyMSmeso): Mixed Methods Study.
Maguire R; Connaghan J; Arber A; Klepacz N; Blyth KG; McPhelim J; Murray P; Rupani H; Chauhan A; Williams P; McNaughton L; Woods K; Moylan A
J Med Internet Res; 2020 Nov; 22(11):e19180. PubMed ID: 33180025
[TBL] [Abstract][Full Text] [Related]
16. The validity and utility of the MD Anderson Symptom Inventory in patients with prostate cancer: evidence from the Symptom Outcomes and Practice Patterns (SOAPP) data from the Eastern Cooperative Oncology Group.
Jones D; Zhao F; Fisch MJ; Wagner LI; Patrick-Miller LJ; Cleeland CS; Mendoza TR
Clin Genitourin Cancer; 2014 Feb; 12(1):41-9. PubMed ID: 24126238
[TBL] [Abstract][Full Text] [Related]
17. Content validity and electronic PRO (ePRO) usability of the Lung Cancer Symptom Scale-Mesothelioma (LCSS-Meso) in mesothelioma patients.
Gelhorn HL; Skalicky AM; Balantac Z; Eremenco S; Cimms T; Halling K; Hollen PJ; Gralla RJ; Mahoney MC; Sexton C
Support Care Cancer; 2018 Jul; 26(7):2229-2238. PubMed ID: 29392480
[TBL] [Abstract][Full Text] [Related]
18. A Cross-sectional Study on the Symptom Burden of Patients With Spinal Tumor: Validation of the Chinese Version of the M.D. Anderson Symptom Inventory-Spine Tumor Module.
Xu N; Li Z; Wei F; Liu X; Jiang L; Meng N; Jiang P; Yu M; Wu F; Dang L; Zhou H; Li Y; Liu Z
J Pain Symptom Manage; 2017 Mar; 53(3):605-613. PubMed ID: 28042067
[TBL] [Abstract][Full Text] [Related]
19. Validation and Application of MD Anderson Symptom Inventory Module for Patients with Bladder Cancer in the Perioperative Setting.
Kamal M; Navai N; Bree KK; Williams LA; Cleeland CS; Shen SE; Wang XS
Cancers (Basel); 2022 Aug; 14(16):. PubMed ID: 36010890
[TBL] [Abstract][Full Text] [Related]
20. Malignant pleural mesothelioma: treatment patterns and humanistic burden of disease in Europe.
Moore A; Bennett B; Taylor-Stokes G; McDonald L; Daumont MJ
BMC Cancer; 2022 Jun; 22(1):693. PubMed ID: 35739480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
